This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flechtner, H. Articles by Bottomley, A. Search for Related Content PubMed PubMed Citation Articles by Flechtner, H. Articles by Bottomley, A.

Fatigue and Quality of Life: Lessons from the Real World

^a Clinic for Psychiatry and Psychotherapy of Children and Adolescents, University of Cologne, Cologne, Germany; ^b EORTC Data Center, Quality of Life Unit, Brussels, Belgium

Correspondence: Henning Flechtner, M.D., Ph.D., Clinic for Psychiatry and Psychotherapy of Children and Adolescents, University of Cologne, Robert-Koch-Str. 10, D, 50931 Cologne, Germany. Telephone: 49-221-478-6121; Fax: 49-221-478-6104; e-mail: henning.flechtner{at}medizin.uni-koeln.de

The impact of fatigue on the quality of life of oncology patients is substantial and under-recognized. Fatigue in these patients may begin with a simple decrease in physical activity, but can progress to include a wide range of negative effects that often culminate in patients feeling out of control, lonely, and isolated. In general, surviving cancer patients experience some limitations after the end of treatment but ultimately attain a reasonably good level of functioning. An examination of subpopulations and further analyses of data suggest, however, four different recovery patterns. Patients may: A) improve in their functioning, reach a plateau at approximately year 2 or 3, and then remain at relatively high levels of functioning; B) improve initially, but deteriorate again after year 2 or 3, never reaching the normal stage; C) improve, returning to normal; or D) have a very mixed pattern of high levels of fatigue that is, to date, very difficult to interpret. Disturbingly, 60% of the survivors in our population of patients with Hodgkin’s disease, who were treated in recent trials of the German Hodgkin Study Group and the European Organization for Research and Treatment of Cancer Lymphoma Group, had medium to high levels of fatigue after 5 cancer-free years. Investigations are essential to determine the current status of long-term survivors in more detail and to link that status to conditions observed during the treatment of acutely ill patients.

Key Words. Fatigue • Quality of life • Anemia • Neoplasms

This article has been cited by other articles:

				E. J. Corwin, L. E. Murray-Kolb, and J. L. Beard Low Hemoglobin Level Is a Risk Factor for Postpartum Depression J. Nutr., December 1, 2003; 133(12): 4139 - 4142. [Abstract] [Full Text] [PDF]

				E. K. Rowinsky Crossing the Cancer Cell Membrane to Improve Clinical Outcomes Oncologist, December 1, 2003; 8(90003): 1 - 4. [Full Text] [PDF]

				P. A. Daly Introduction: All Ireland Fatigue Coalition Oncologist, February 1, 2003; 8(90001): 1 - 2. [Abstract] [Full Text] [PDF]